Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00692380 · ClinicalTrials.gov registry record · Phase 1
Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00692380 is a Phase 1 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 28 participants.
The verdict
NCT00692380, a Phase 1 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
Radiation therapy technology that allows increased radiation dose to the tumor while sparing healthy tissue will improve the balance between complications and cure.
Interventions
- RADIATION Fractionated radiation therapy followed by chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-06 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00692380
The ClinicalTrials.gov registry entry for NCT00692380 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fractionated radiation therapy followed by chemotherapy is the first listed.
NCT00692380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00692380 about?
NCT00692380 is a clinical study titled "Gated Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Inoperable NSCLC". Radiation therapy technology that allows increased radiation dose to the tumor while sparing healthy tissue will improve the balance between complications and cure.
What is the current status of trial NCT00692380?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2006-06. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00692380?
The interventions under investigation include: Fractionated radiation therapy followed by chemotherapy (RADIATION).
Who is sponsoring clinical trial NCT00692380?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.